The US National Institutes of Health (NIH) announced it continues to recommend anti-SARS-CoV-2 monoclonal antibodies that target the SARS-CoV-2 spike protein and block coronavirus entry into cells that have been evaluated for the treatment of COVID-19.
However, on April 8, 2021, the NIH confirmed changes to the monoclonal antibody cocktail recommendations.
COVID-19 Treatment Guidelines Updated for Anti-SARS-CoV-2 Monoclonal Antibodies
Fake Vaccine Passports Causing COVID-19 Pandemic Confusion
During 2021, a number of COVID-19 vaccination “passport” initiatives have launched that could make traveling during the pandemic become easier for consumers.
Since yellow fever vaccination certificates have been globally accepted for years, these digital COVID-19 vaccine passports should be widely accepted.
However, several US states have already said, not so fast.
As of April 9, 2021, the states of Texas, Florida, Georgia, and others have issued orders to confront this growing movement of vaccine passports.
Antibodies Persist Six Months After Second Dose of Moderna COVID-19 Vaccine
Neutralizing antibody titers significantly lower in those older than 55 years versus those 18 to 55 years of age
Blood Type Not Associated With COVID-19 Outcomes
No associations seen for disease susceptibility, severity, or outcomes for either White populations or diverse populations
Mortality Risk Up for Dialysis Patients in March to July 2020
Higher death rates seen in 2020 versus same time period in 2017 to 2019 among patients who were on dialysis or had a functioning transplant
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 5 to 9, 2021. This …
In-Hospital SARS-CoV-2 Mortality Declined Throughout Pandemic
Authors say reductions in in-hospital mortality likely due to new therapies and improvements in clinical management of patients with SARS-CoV-2
Decrease Seen in Suicide Rate in the United States
Decrease seen despite concerns there would be more suicides due to the COVID-19 pandemic
Supply of J&J COVID-19 Vaccine to Drop 86 Percent Next Week
And, North Carolina has stopped administering Johnson & Johnson vaccines after at least 26 people experienced adverse reactions
First Living Donor Transplant of Lung Tissue to COVID-19 Patient Announced
Female recipient received lung tissue donated by her husband and son
- Page 1 of 2
- 1
- 2